Such a diet emphasises whole plant foods while minimising animal products, promoting better gut health, insulin sensitivity, and improved metabolic markers
External resources Injection technique and insulin delivery: clinical evidence and practical guidance , National Institutes of Health, PubMed Central
Myth 2: It doesn't matter what you eat on a GLP-1 - the medication does all the work
The evidence sitting under both brands Whatever logo is on the box, the pharmacology traces back to the compound class: GLP-1 receptor agonists such as semaglutide, liraglutide, and dulaglutide, plus the GIP/GLP-1 dual agonist tirzepatide
A large, multiyear study that showed semaglutide reduced risk of heart attack and stroke by 20 percent helped Wegovy gain FDA approval as a treatment for cardiovascular disease in March 2024
Therefore, individual treatment results may vary